Physician profile
Michael Blotner
NPI 1326129982
$1,283.42
in general payments reported to CMS, 2019-2025
13 companies · $62.89 in 2025
The $62.89 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $148 · 2021: $194 · 2022: $343 · 2023: $293 · 2024: $42.45 · 2025: $62.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $523.07 | 2019-2023 | Orilissa |
| Myovant Sciences INC. | $226.53 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $122.39 | 2023-2025 | Myfembree |
| Myriad Women'S Health, INC. | $69.66 | 2023 | |
| Pfizer INC. | $65.39 | 2023 | |
| Merck Sharp & Dohme LLC | $63.95 | 2019-2021 | |
| Mission Pharmacal Company | $45.45 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $40.05 | 2021-2022 | |
| Organon LLC | $31.81 | 2021-2022 | |
| Hologic Sales and Service, LLC | $30.06 | 2019 | |
| Meditrina | $28.10 | 2025 | |
| Therapeuticsmd, INC. | $20.12 | 2019 | |
| Exeltis, USA INC. | $16.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Blotner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.